Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

α1-Adrenoceptor Subtypes Mediating Inotropic Responses in Rat Heart

You-Yi Zhang, Kai-Ming Xu and Chide Han
Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 829-836;
You-Yi Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai-Ming Xu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chide Han
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We studied the distribution of α1-adrenoceptor subtypes by radioligand binding assays using 125I-labeled 2-β(4-hydroxyphenyl)-ethylaminomethyl)-tetralone (BE2254) and RNase protection assays, and determined the role of each subtype in mediating the inotropic response in rat heart. Chlorethylclonidine preincubation causes a ∼72% decrease in the maximal binding capacity (Bmax). On the other hand, protection from phenoxybenzamine alkylation by 5-methyl-urapidil or BMY7378 decreasedBmax by 59 and 70%. By competitive inhibition, we have identified 19 to 28% and 30% high-affinity binding sites for the α1A- and α1D-selective antagonists in rat ventricles, with the α1B-adrenoceptor estimated as 45%. Consistent with the receptor-binding result, a similar distribution of mRNAs encoding α1A, α1B, and α1D (22, 39, and 39%), based on RNase protection assays, was observed. In addition, we demonstrated that the noradrenaline response through α1-adrenoceptor was antagonisted by 5-methyl-urapidil, RS-17053, BMY7378, and WB4101 in contraction functional experiments. KI values for the above compounds were defined for all three α1-adrenoceptor subtypes expressed in the human embryonic kidney 293 cell stably, and were further compared with the corresponding pA2 values. Interestingly, the correlation was significantly higher for α1A(r2 = 0.73) and α1B(r2 = 0.66) than α1D(r2 = 0.35) in these experiments. Because the potential of α1D measured to be 21% based on protection from phenoxybenzamine-caused inhibition by BMY7378, the combined potential of α1A and α1B can be estimated as ∼80%. Taken together, these results suggest that the three α1-adrenoceptor subtypes coexist in rat heart, with α1A and α1B playing a more prominent role in the positive inotropic response to noradrenaline.

Footnotes

  • Send reprint requests to: Dr. Chide Han, Institute of Vascular Medicine, Third Hospital, Beijing Medical University, Beijing 100083 China. E-mail: hanqd{at}mail.bjmu.edu.cn

  • ↵1 This work was supported by grants from the National Science Foundation of China and by China Medical Board of New York Inc. Grant 93–591.

  • Abbreviations:
    WB4101
    2-(2,6-dimethoxphenoxyethyl)-aminomethyl-1,4 benzodioxane
    BE2254
    2-β(4-hydroxyphenyl)-(ethylaminomethyl)-tetralone
    CEC
    chlorethylclonidine
    BMY7378
    8-[2-[4[-(2-methoxyphenly)-1-piperazinyl]-8-azaspiro]4,5]decane-7,9-dione dihydrochloride
    5-MU
    5-methyl-urapidil
    POB
    phenoxybenzamine
    RBA
    radioligand binding assays
    RS-17053
    N-[2–2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-α,α-dimethyl-1H-indole-3-ethanamine hydrochloride
    HEK
    human embryonic kidney
    bp
    base pair
    • Received May 21, 1999.
    • Accepted August 4, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 291 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 291, Issue 2
1 Nov 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
α1-Adrenoceptor Subtypes Mediating Inotropic Responses in Rat Heart
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

α1-Adrenoceptor Subtypes Mediating Inotropic Responses in Rat Heart

You-Yi Zhang, Kai-Ming Xu and Chide Han
Journal of Pharmacology and Experimental Therapeutics November 1, 1999, 291 (2) 829-836;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

α1-Adrenoceptor Subtypes Mediating Inotropic Responses in Rat Heart

You-Yi Zhang, Kai-Ming Xu and Chide Han
Journal of Pharmacology and Experimental Therapeutics November 1, 1999, 291 (2) 829-836;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Pharmacodynamics of Immunosuppression by Mycophenolic Acid: Inhibition of Both Lymphocyte Proliferation and Activation Correlates with Pharmacokinetics
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics